Approvals for Clinical Trial Applications

Approved Clinical Trial Applications can be found in The European Union Clinical Trials Register, https://www.clinicaltrialsregister.eu/

2019

The IMA has approved five clinical trials in the year 2019

On the 10th of October 2019 IMA approved a multinational phase III trial for oncology. 

On the 26th of June 2019 IMA approved a multinational phase II trial for atopic dermatitis.

On the 6th of March 2019 IMA approved a clinical trial for a genetic disease. This is a phase IIa trial only performed in Iceland.

On the 4th of March 2019 IMA approved a multinational phase II trial for atopic dermatitis.

On the 4th of March 2019 IMA approved a multinational phase IIIb trial for atopic dermatitis.

2018

The IMA has approved three clinical trials in the year 2018

On 12 December 2018 IMA approved a multinational phase II trial in oncology. 

On the 29th of November 2018 IMA approved a trial in oncology. This is a phase II trial only performed in Iceland.

On the 29th of May 2018 IMA approved a multinational phase II trial for atopic dermatitis.

2017

The IMA has approved five clinical trials in the year 2017

On the 22nd of September IMA approved a multinational phase II/III trial for dementia.

On the 11th of April 2017 IMA approved a trial in cardiology. This is a phase IV trial only performed in Iceland.

On the 11th of April 2017 IMA approved a multinational phase IIIb trial in rheumatology.

On the 27th of March 2017 IMA approved a multinational phase IIIb trial in cardiology.

On the 12th of January 2017 IMA approved a multinational phase III trial in dermatology.

2016

The IMA has approved nine clinical trials in the year 2016

On 30 December 2016 IMA approved a multinational phase III trial in gastroenterology.

On 30 December 2016 IMA approved a multinational phase III trial in gastroenterology.

On 21 December 2016 IMA approved a multinational phase IIb/III trial in gastroenterology.

On 21 December 2016 IMA approved a multinational phase III trial in gastroenterology.

On 21 September 2016 IMA approved a multinational phase IIIb trial in dermatology.

On 8 June 2016 IMA approved a multinational phase IV trial in oncology.

On 4 May 2016 IMA approved a multinational phase III trial in dermatology.

On 28 April 2016 IMA approved a multinational phase II/III trial in gastroenterology.

On 7 April 2016 IMA approved a multinational phase II trial in gastroenterology.

2015

The IMA has approved seven clinical trials in the year 2015 

On 29 December 2015 IMA approved a multinational phase III trial in respiratory disease.  

On 30 November 2015 IMA approved a clinical trial in dermatology. This is a phase IV trial only performed in Iceland.  

On 2 July 2015 IMA approved a multinational phase II trial in immunology.  

On 29 June 2015 IMA approved a trial in gastroenterology. This is a phase IV trial only performed in Iceland.  

On 17 March 2015 IMA approved a multinational phase III trial in cardiology.  

On 10 February 2015 IMA approved multinational phase III trial in cardiology.  

On 23 January 2015 IMA approved a multinaltional phase II trial in dermotology.